Home

"TLA has become an indispensable tool to characterize transgene insertion events and complex gene targeting approaches."

Taconic
Dr. Jochen Welcker - Director Molecular Biology & Scientific Development

"Cergentis quickly determined transgene insertion for three out of three lines along with providing information on deletions and rearrangements in chromosomal DNA at the site. The service was quick, accurate and reasonably priced, and reports were complete and helpful.”

Harvard University
Prof. Dr. Joshua Sanes - Department of Molecular and Cellular Biology

"Working with the team at Cergentis has allowed us to add an extra dimension to the analysis of our stable cell lines. Their understanding of our needs combined with the reliability and reproducibility of TLA analysis has resulted in a number of successful projects."

Teva Pharmaceuticals
Dr. Teresa Domagala
  • Latest news

  • Empowering advanced genetic engineering
    &
    precision medicine

  • Upcoming events

    30 | 11 | 2021 / 3 | 12 | 2021 - Conferences
    Read more
  • APPNOTES

    Read more
  • TLA technology

    Read more
  • Publications

    Read more
© 2012-2021 Cergentis B.V. All rights reserved.
For Research Use Only.Not for use in diagnostic procedures.
We use cookies for website analysis and marketing. By visiting and using our website you accept these cookies.
ACCEPT